Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Overall Study	STARTED	Ulipristal Acetate (PGL4001) 5mg	228
Overall Study	STARTED	Ulipristal Acetate (PGL4001) 10mg	223
Overall Study	Safety Population	Ulipristal Acetate (PGL4001) 5mg	230
Overall Study	Safety Population	Ulipristal Acetate (PGL4001) 10mg	221
Overall Study	Started Treatment Course 2	Ulipristal Acetate (PGL4001) 5mg	213
Overall Study	Started Treatment Course 2	Ulipristal Acetate (PGL4001) 10mg	207
Overall Study	Started Treatment Course 3	Ulipristal Acetate (PGL4001) 5mg	191
Overall Study	Started Treatment Course 3	Ulipristal Acetate (PGL4001) 10mg	190
Overall Study	Started Treatment Course 4	Ulipristal Acetate (PGL4001) 5mg	178
Overall Study	Started Treatment Course 4	Ulipristal Acetate (PGL4001) 10mg	176
Overall Study	COMPLETED	Ulipristal Acetate (PGL4001) 5mg	167
Overall Study	COMPLETED	Ulipristal Acetate (PGL4001) 10mg	170
Overall Study	NOT COMPLETED	Ulipristal Acetate (PGL4001) 5mg	61
Overall Study	NOT COMPLETED	Ulipristal Acetate (PGL4001) 10mg	53

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01629563/flow